FDA announced extended use dates for some parenteral drug products, after a review of the stability data submitted by Baxter International: fda.gov/drugs/updates-… Search FDA's list of extended use dates to assist with drug shortages: fda.gov/drugs/drug-sho…

Holiday celebrations are approaching. With an increase in social gatherings comes the likelihood of an increase in positive COVID-19 cases. Testing helps prevent and contain the spread of COVID-19. fda.gov/covidtestdates…

If you work with dairy cows or other animals that could be infected with #birdflu, take action to reduce your risk of infection. Read more here: bit.ly/4dADJBK

One Health involves everyone. A successful #OneHealth approach to public health involves many experts working together to improve the health of people, animals — including pets, livestock, and wildlife – plants, and the environment. #OneHealthDay bit.ly/3YinvIV

Missed One Health Day? Take time now to reflect that the best possible health outcomes are achieved by considering the interconnectedness of humans, animals & the environment. See FDA CVM (Center for Veterinary Medicine) for more info and to sign up for an upcoming symposium: fda.gov/animal-veterin…

📣 Join #CDERSBIA on December 10-12 for a virtual training course to provide participants with the essential knowledge and skills to conduct clinical trials effectively, ethically, & in accordance with regulatory standards. Learn more & register today ➡ fda.gov/drugs/news-eve…

CDC has #H5N1 #birdflu resources that are searchable by language. Fact sheets, videos, infographics, and other resources in multiple languages are available for partners. More here: bit.ly/3TRP4X5

U.S. Antibiotic Awareness Week starts soon! ‘Go Purple’ anytime during November 18-24 to show how we all play a role in fighting #AntimicrobialResistance. Learn how you can ‘Go Purple’ and encourage others to do the same for #USAAW24 bit.ly/4bo2Bf1

CDC issues Health Alert Network (HAN) Health Advisory to provide information about the first case of clade I mpox diagnosed in the U.S. and recommendations to clinicians about preventing, diagnosing, treating, and reporting mpox cases. Read full alert: bit.ly/4exL5q8

Today, the U.S. FDA issued the final guidance, “510(k) Third Party Review Program and Third Party Emergency Use Authorization (EUA) Review.” This guidance supersedes the previous "510(k) Third Party Review Program" guidance. fda.gov/regulatory-inf…

Antibiotic and antifungal drugs are valuable tools for treating infections, but any time they are used they can cause side effects and contribute to #AntimicrobialResistance (AR). Learn how the appropriate use of these drugs can help fight AR: bit.ly/3zhewOm #USAAW24

#ICYMI: 📢 Join #CDERSBIA on December 10-12 for a virtual training course to provide participants with the essential knowledge and skills to conduct clinical trials effectively, ethically, and in accordance with regulatory standards. Register today ➡ fda.gov/drugs/news-eve…

An #AntimicrobialResistance (AR) threat somewhere can become a threat anywhere. Modern travel of people, animals, and goods means AR can easily spread. Take precautions to help ensure a healthy and safe travel season and help combat AR at the same time: bit.ly/2ATfgIN

It’s a new Year, but you may not need a new test! Before you toss, check the dates of your at-home covid tests. Your tests might still be good—check the FDA website for extended expiration dates on many at home covid-19 tests. fda.gov/covidtestdates…

Today, U.S. FDA announced the availability of a draft guidance for industry titled “Study of Sex Differences in the Clinical Evaluation of Medical Products.” Read it to learn why analyzing sex-related differences in medical product response matters. fda.gov/regulatory-inf…

Today, the U.S. FDA issued the final guidance titled, Notifying FDA of a Permanent Discontinuance or Interruption in Manufacturing of a Device Under Section 506J of the FD&C Act. Find out more: fda.gov/regulatory-inf…

Read our statement on #MedicalDevice supply chain vulnerabilities, the public health impact they have on our most vulnerable populations, such as neonatal and pediatric patients, our actions to prevent and mitigate potential shortages, and solutions. fda.gov/medical-device…

The FDA is committed to promoting patient access to safe and effective medical products and ensuring a secure food supply. Learn more about how we work with @HHSgov and other partners to address shortages of FDA-regulated products: fda.gov/emergency-prep…